Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-16-0125
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

Neurologia Medico-Chirurgica
SurgeryNeurology
2018English

DNA-methylation-mediated Activating of lncRNA SNHG12 Promotes Temozolomide Resistance in Glioblastoma

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2020English

Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma

Cells
2019English

A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Metformin and Temozolomide, a Synergic Option to Overcome Resistance in Glioblastoma Multiforme Models

Oncotarget
Oncology
2017English

Temozolomide Nanoparticles for Targeted Glioblastoma Therapy

ACS Applied Materials & Interfaces
MedicineMaterials ScienceNanotechnologyNanoscience
2015English

RRAD Promotes EGFR-Mediated STAT3 Activation and Induces Temozolomide Resistance of Malignant Glioblastoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy